Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.